Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(43 sites)

China

Peking University First Hospital, Beijing, Beijing Municipality

The First Affiliated Hospital of Baotou Medical College, Baotou

Beijing Anzhen Hospital, Beijing

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

China-Japan Union Hospital of Jilin University, Changchun